This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not commonly a part of the monthly accounts receivable maintenance? A) ... (Read 25 times)

azncindy619

  • Hero Member
  • *****
  • Posts: 562
Which of the following is not commonly a part of the monthly accounts receivable maintenance?
 A) rebilling
  B) claim follow-up
  C) reviewing aging reports
 D)reviewing overhead expenses

Question 2

Which of the following describes the resubmitting of a claim?
 A) follow-up
  B) rebill
  C) age
 D)process



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

debra928

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

D

Answer to Question 2

B




azncindy619

  • Member
  • Posts: 562
Reply 2 on: Jun 27, 2018
Gracias!


zacnyjessica

  • Member
  • Posts: 345
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The familiar sounds of your heart are made by the heart's valves as they open and close.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library